Literature DB >> 32066116

The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis.

Tingting Lv1, Fengfan Yang2, Kui Zhang2, Minghua Lv2, Yan Zhang3, Ping Zhu4.   

Abstract

To ascertain the number and percentage of angiogenic T (Tang) cell subsets by flow cytometry in systemic sclerosis (SSc), and their relation with specific clinical features. Thirty SSc patients and 15 healthy controls (HCs) were included. Luminex was performed to analyze the levels of interleukin (IL)-17A, vascular endothelial growth factor (VEGF), tumor necrosis factor-α, and vascular cell adhesion molecule (VCAM). The ratio of circulating CD3 + CD31 + CXCR4 + T (CD3 + Tang) cells and CD8+ CD31 + CXCR4 + T (CD8+ Tang) cells in SSc patients was enlarger than in HCs, while CD4 + CD31 + CXCR4 + T cells (CD4 + Tang) exhibited no difference between SSc patients and HCs. The number and percentage of Tang cells were higher in SSc patients with pulmonary artery hypertension (PAH) than in non-PAH SSc patients and HCs. The ratios of Tang cell subsets in nucleolar pattern-positive SSc patients were markedly raised as compared with their negative ones and HCs. Additionally, the percentage of circulating CD3 + Tang cells was positively associated with VEGF serum levels in SSc patients. Meanwhile, the rate of CD8+ tang cells might have been emphatically corresponded to VEGF and VCAM serum levels in SSc patients. These results imply that the increase in Tang cells in peripheral blood are associated with immunoregulatory disturbances in SSc patients.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenic T cells; Pulmonary artery hypertension; Systemic sclerosis; Vasculopathy

Mesh:

Substances:

Year:  2020        PMID: 32066116     DOI: 10.1016/j.intimp.2020.106282

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?

Authors:  Verónica Pulito-Cueto; Sara Remuzgo-Martínez; Fernanda Genre; Belén Atienza-Mateo; Víctor M Mora-Cuesta; David Iturbe-Fernández; Leticia Lera-Gómez; Javier Rodriguez-Carrio; Diana Prieto-Peña; Virginia Portilla; Ricardo Blanco; Alfonso Corrales; Oreste Gualillo; José M Cifrián; Raquel López-Mejías; Miguel A González-Gay
Journal:  Biomedicines       Date:  2022-04-05

Review 2.  Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases.

Authors:  Liala Moschetti; Silvia Piantoni; Enrico Vizzardi; Edoardo Sciatti; Mauro Riccardi; Franco Franceschini; Ilaria Cavazzana
Journal:  Front Med (Lausanne)       Date:  2022-04-08

3.  The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.

Authors:  Alessandra Bortoluzzi; Cecilia Beatrice Chighizola; Micaela Fredi; Elena Raschi; Caterina Bodio; Daniela Privitera; Arianna Gonelli; Ettore Silvagni; Marcello Govoni; Ilaria Cavazzana; Paolo Airò; Pier Luigi Meroni; Angela Tincani; Franco Franceschini; Silvia Piantoni; Fabio Casciano
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.